New hope for advanced cancer patients as novel drug trial begins
NCT ID NCT06634849
Summary
This early-stage trial is testing a new oral drug called PTT-4256 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that the drug might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Blacktown Hospital
RECRUITINGBlacktown, New South Wales, 2148, Australia
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit (SOCRU)
RECRUITINGAdelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.